All Stories

  1. Allenamides as a Powerful Tool to Incorporate Diversity: Thia‐Michael Lipidation of Semisynthetic Peptides and Access to β‐Keto Amides
  2. Allenamides as a Powerful Tool to Incorporate Diversity: Thia‐Michael Lipidation of Semisynthetic Peptides and Access to β‐Keto Amides
  3. Antiparasitic effect of peptoids againstCryptosporidium parvum
  4. Current and novel therapies for management of Acinetobacter baumannii -associated pneumonia
  5. Site-Specific Antimicrobial Activity of a Dual-Responsive Ciprofloxacin Prodrug
  6. Using host-mimicking conditions and a murine cutaneous abscess model to identify synergistic antibiotic combinations effective against Pseudomonas aeruginosa
  7. Biodistribution of Native and Nanoformulated Innate Defense Regulator Peptide 1002
  8. Murepavadin promotes the killing efficacies of aminoglycoside antibiotics against Pseudomonas aeruginosa by enhancing membrane potential
  9. Repurposing ebselen as an inhalable dry powder to treat respiratory tract infections
  10. Effectiveness of gold nanoparticles in prevention and treatment of oral mucositis in animal models: a systematic review
  11. Size-Controlled Synthesis of Gold Nanoparticles Tethering Antimicrobial Peptides with Potent Broad-Spectrum Antimicrobial and Antibiofilm Activities
  12. Novel intranasal phage-CaEDTA-ceftazidime/avibactam triple combination therapy demonstrates remarkable efficacy in treating Pseudomonas aeruginosa lung infection
  13. Murepavadin induces envelope stress response and enhances the killing efficacies of β-lactam antibiotics by impairing the outer membrane integrity of Pseudomonas aeruginosa
  14. Surviving the host: Microbial metabolic genes required for growth of Pseudomonas aeruginosa in physiologically-relevant conditions
  15. The ColR/S two-component system is a conserved determinant of host association across Pseudomonas species
  16. Inhalable ceftazidime-roflumilast powder targeting infection and inflammation: Influence of incorporating roflumilast into ceftazidime-leucine co-amorphous formulation
  17. Three-Dimensional Printed Cellulose for Wound Dressing Applications
  18. Biodistribution and toxicity of innate defense regulator 1018 (IDR-1018)
  19. Targeting the Pseudomonas aeruginosa Virulence Factor Phospholipase C With Engineered Liposomes
  20. Self-Assembly of Antimicrobial Peptoids Impacts Their Biological Effects on ESKAPE Bacterial Pathogens
  21. Antibiofilm and immunomodulatory resorbable nanofibrous filing for dental pulp regenerative procedures
  22. Ultraviolet-C Irradiation, Heat, and Storage as Potential Methods of Inactivating SARS-CoV-2 and Bacterial Pathogens on Filtering Facepiece Respirators
  23. 3D printed cellulose based product applications
  24. Cellulose composites containing active constituents of coffee and tea: a prospective novel wound dressing
  25. The ColR/S two-component system is a conserved determinant of host association across Pseudomonas species
  26. Enzymatically releasable polyethylene glycol – host defense peptide conjugates with improved activity and biocompatibility
  27. Synergistic bactericidal activities of tobramycin with ciprofloxacin and azithromycin against Klebsiella pneumoniae
  28. Peptide 1018 inhibits swarming and influences Anr-regulated gene expression downstream of the stringent stress response in Pseudomonas aeruginosa
  29. Treatment with a neutrophil elastase inhibitor and ofloxacin reduces P. aeruginosa burden in a mouse model of chronic suppurative otitis media
  30. Murine Model of Sinusitis Infection for Screening Antimicrobial and Immunomodulatory Therapies
  31. Friends or enemies? The complicated relationship between Pseudomonas aeruginosa and Staphylococcus aureus
  32. Human organoid biofilm model for assessing antibiofilm activity of novel agents
  33. Towards understanding single-channel characteristics of OccK8 purified from Pseudomonas aeruginosa
  34. Rapid microwave-based method for the preparation of antimicrobial lignin-capped silver nanoparticles active against multidrug-resistant bacteria
  35. Contribution of swarming motility to dissemination in a Pseudomonas aeruginosa murine skin abscess infection model
  36. Identification of novel targets of azithromycin activity against Pseudomonas aeruginosa grown in physiologically relevant media
  37. Host Defense Peptide-Mimicking Amphiphilic β-Peptide Polymer (Bu:DM) Exhibiting Anti-Biofilm, Immunomodulatory, and in Vivo Anti-Infective Activity
  38. Mechanistic Understanding Enables the Rational Design of Salicylanilide Combination Therapies for Gram-Negative Infections
  39. A cyclic derivative of host-defence peptide IDR-1018 improves proteolytic stability, suppresses inflammation, and enhances in vivo activity
  40. The Stringent Stress Response Controls Proteases and Global Regulators under Optimal Growth Conditions in Pseudomonas aeruginosa
  41. A novel mouse model of chronic suppurative otitis media and its use in preclinical antibiotic evaluation
  42. The stringent stress response controls proteases and global regulators under optimal growth conditions in Pseudomonas aeruginosa
  43. Rough-type and loss of the LPS due to lpx genes deletions are associated with colistin resistance in multidrug-resistant clinical Escherichia coli isolates not harbouring mcr genes
  44. NtrBC Regulates Invasiveness and Virulence of Pseudomonas aeruginosa During High-Density Infection
  45. Mechanistic understanding enables the rational design of salicylanilide combination therapies for Gram-negative infections
  46. Surfing motility is a complex adaptation dependent on the stringent stress response in Pseudomonas aeruginosa LESB58
  47. Hyaluronic acid-based nanogels improve in vivo compatibility of the anti-biofilm peptide DJK-5
  48. Dismantling the bacterial virulence program
  49. Controlling biofilm formation with nitroxide functional surfaces
  50. Aurein-derived antimicrobial peptides formulated with pegylated phospholipid micelles to target methicillin-resistant Staphylococcus aureus skin infections
  51. Is synergy the key to treating high-density infections?
  52. Synergy between conventional antibiotics and anti-biofilm peptides in a murine, sub-cutaneous abscess model caused by recalcitrant ESKAPE pathogens
  53. Liposomal Therapy Attenuates Dermonecrosis Induced by Community-Associated Methicillin-Resistant Staphylococcus aureus by Targeting α-Type Phenol-Soluble Modulins and α-Hemolysin
  54. Helicobacter pylori Biofilm Formation Is Differentially Affected by Common Culture Conditions, and Proteins Play a Central Role in the Biofilm Matrix
  55. TonB-Dependent Receptor Repertoire of Pseudomonas aeruginosa for Uptake of Siderophore-Drug Conjugates
  56. Impact of Host Defense Peptides on Chronic Wounds and Infections
  57. New Perspectives in Biofilm Eradication
  58. Alternative strategies to fight drug resistant bacteria in an abscess infection model
  59. Alternative strategies for the study and treatment of clinical bacterial biofilms
  60. A Single Residue Acts as Gate in OccK Channels
  61. New Mouse Model for Chronic Infections by Gram-Negative Bacteria Enabling the Study of Anti-Infective Efficacy and Host-Microbe Interactions
  62. Structure and Function of the PiuA and PirA Siderophore-Drug Receptors from Pseudomonas aeruginosa and Acinetobacter baumannii
  63. Mechanisms of intrinsic resistance and acquired susceptibility of Pseudomonas aeruginosa isolated from cystic fibrosis patients to temocillin, a revived antibiotic
  64. The bacteriophage‐derived transcriptional regulator, LscR, activates the expression of levansucrase genes in Pseudomonas syringae
  65. Anti-biofilm peptides as a new weapon in antimicrobial warfare
  66. Bacterial Abscess Formation Is Controlled by the Stringent Stress Response and Can Be Targeted Therapeutically
  67. Draft Genome Sequence of Dietzia maris DSM 43672, a Gram-Positive Bacterium of the Mycolata Group
  68. Antibiofilm Peptides: Potential as Broad-Spectrum Agents
  69. Swarming motility is modulated by expression of the putative xenosiderophore transporter SppR-SppABCD in Pseudomonas aeruginosa PA14
  70. Marinobacter adhaerens HP15 harbors two CzcCBA efflux pumps involved in zinc detoxification
  71. The Pseudomonas aeruginosa PA14 ABC Transporter NppA1A2BCD Is Required for Uptake of Peptidyl Nucleoside Antibiotics
  72. Role of the cell envelope stress regulators BaeR and CpxR in control of RND-type multidrug efflux pumps and transcriptional cross talk with exopolysaccharide synthesis in Erwinia amylovora
  73. Expression of extra-cellular levansucrase in Pseudomonas syringae is controlled by the in planta fitness-promoting metabolic repressor HexR
  74. Identification, characterization, isolation and activity against Escherichia coli of quince (Cydonia oblonga) fruit polyphenols
  75. High-Throughput Screening of Dipeptide Utilization Mediated by the ABC Transporter DppBCDF and Its Substrate-Binding Proteins DppA1-A5 in Pseudomonas aeruginosa
  76. AraC/XylS Family Stress Response Regulators Rob, SoxS, PliA, and OpiA in the Fire Blight Pathogen Erwinia amylovora
  77. Characterization and regulation of the Resistance-Nodulation-Cell Division-type multidrug efflux pumps MdtABC and MdtUVW from the fire blight pathogen Erwinia amylovora
  78. Characterization of AcrD, a Resistance-Nodulation-Cell Division-type multidrug efflux pump from the fire blight pathogen Erwinia amylovora
  79. Enhanced expression of codon optimized Mycobacterium avium subsp. paratuberculosis antigens in Lactobacillus salivarius
  80. The conserved upstream region of lscB/C determines expression of different levansucrase genes in plant pathogen Pseudomonas syringae
  81. Codon optimisation to improve expression of aMycobacterium aviumssp.paratuberculosis-specific membrane-associated antigen byLactobacillus salivarius
  82. Phylogenetic detection of horizontal gene transfer during the step-wise genesis of Mycobacterium tuberculosis